Skip to main content

Agilent Technologies (NYSE: A) — Company Overview, News & Financial Data

Agilent Technologies logo
A Agilent Technologies
Agilent Technologies primary media
Company profile

Agilent Technologies

Agilent Technologies is a global provider of analytical instruments, software, services, consumables, and diagnostics solutions for life sciences, clinical diagnostics, and applied chemical markets. Spun off from Hewlett-Packard in 1999, the company manufactures liquid and gas chromatography systems, mass spectrometers, molecular biology reagents, and tissue pathology tools. Its products serve laboratories engaged in pharmaceutical drug discovery, bioanalytical testing, clinical diagnostics, food safety verification, environmental monitoring, and materials research. Headquartered in Santa Clara, California, Agilent maintains administrative offices, research facilities, and production plants across North America, Europe, and Asia-Pacific to support laboratory workflows globally.

Snapshot

Public USOwnership
1999Year founded
~16,000Employees
Santa Clara, United StatesHead office
Loading Map...
Global footprint

Operations

Products and/or services of Agilent Technologies

  • Life Sciences Instrumentation: High-performance gas and liquid chromatography systems, mass spectrometers, and atomic spectroscopy instruments designed for drug discovery, pharmaceutical quality control, academic research, and structural biology analysis across global analytical testing laboratories.
  • Agilent CrossLab Services: Comprehensive laboratory enterprise services, analytical instrument maintenance, enterprise asset management, regulatory compliance support, and workflow consulting designed to optimize laboratory operations and equipment uptime across pharmaceutical and industrial facilities.
  • Diagnostics and Pathology Solutions: Reagents, primary antibodies, automated immunohistochemistry instruments, molecular pathology assays, and tissue staining platforms supplied to hospital and independent clinical pathology laboratories for precision cancer diagnostics and companion diagnostic development.
  • Chromatography Consumables and Supplies: Sample preparation kits, liquid and gas chromatography columns, microfluidics components, specialized vials, and laboratory reagents engineered to enable precise chemical separation, sample cleanup, and sample handling across analytical testing workflows.
  • Genomics and Automation Systems: Next-generation sequencing library preparation automation, microfluidic nucleic acid analysis platforms, target enrichment assays, target capture reagents, and quantitative PCR systems utilized in clinical genomics and life science research applications.
  • Applied Markets Instrumentation: Specialized chemical testing equipment, gas chromatographs, and spectroscopy instruments deployed in industrial facilities for food safety testing, environmental water and air monitoring, petrochemical analysis, and forensic analysis.

Agilent Technologies executive team

  • Padraig McDonnellCEO, President & Director
  • Rodney GonsalvesVice President of Finance
  • Angelica A. RiemannSenior VP & President of Agilent CrossLab Group
  • Simon MaySenior VP and President of Life Sciences & Diagnostics Markets Group
  • Bret M. DiMarcoSpecial Advisor
  • Adam S. ElinoffSenior VP, CFO & Principal Financial Officer
  • Tim DownsVP & Chief Accounting Officer
  • August SpechtSenior VP & Chief Technology Officer
  • Tejas Rajeev SavantVice President of Investor Relations
  • Michael BucknerSenior VP, Chief Legal Officer & Secretary

Dividend history

Dividends per share paid by Agilent Technologies, by financial year.

Agilent Technologies dividends per share by financial year
Financial yearInterimFinalSpecialTotal
FY2026———$1.0200
FY2025———$0.9920
FY2024———$0.9440
FY2023———$0.9000
FY2022———$0.8400

Key financials

Reported results for Agilent Technologies, in USD.

Market cap
49.5B
Revenue (TTM)
7.4B
P/E ratio
34.6
EPS (diluted, TTM)
5.1
Dividend yield
0.6%
Profit margin
19.5%
Agilent Technologies annual revenue and income
Fiscal year endRevenueOperating incomeNet income
6.9B1.5B1.3B
6.5B1.5B1.3B
6.8B1.4B1.2B
6.8B1.6B1.3B